AMANDA YOUNG: Open Payments
NPI 1982075735 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 68 payments from 27 companies in 2025. Trend: 2023 $2,073 · 2024 $1,989 · 2025 $1,468
Food & beverage: $1,368Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $116 |
| PFIZER INC. | 6 | $107 |
| SEAGEN INC. | 1 | $100 |
| ABBVIE INC. | 4 | $92 |
| BeOne Medicines USA, Inc. | 4 | $76 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Calliditas Therapeutics US Inc. | 2 | $60 |
| Genentech USA, Inc. | 3 | $58 |
| Janssen Biotech, Inc. | 3 | $56 |
Products named: ICLUSIG, SCEMBLIX, VENCLEXTA, KEYTRUDA, KISQALI, TARPEYO, PLUVICTO, BRUKINSA.
Industry payments across AL — which companies pay providers there.
